• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. ERS Clinical Practice Guidelines: high-flow nasal cannula in acute respiratory failure.
 

ERS Clinical Practice Guidelines: high-flow nasal cannula in acute respiratory failure.

Options
  • Details
BORIS DOI
10.48350/160267
Date of Publication
April 2022
Publication Type
Article
Division/Institute

Institut für Sozial- ...

Author
Oczkowski, Simon
Ergan, Begüm
Bos, Lieuwe
Chatwin, Michelle
Ferrer, Miguel
Gregoretti, Cesare
Heunks, Leo
Frat, Jean-Pierre
Longhini, Federico
Nava, Stefano
Navalesi, Paolo
Uğurlu, Aylin Ozsancak
Pisani, Lara
Renda, Teresa
Thille, Arnaud W
Winck, João Carlos
Windisch, Wolfram
Tonia, Thomaiorcid-logo
Institut für Sozial- und Präventivmedizin (ISPM)
Boyd, Jeanette
Sotgiu, Giovanni
Scala, Raffaele
Subject(s)

600 - Technology::610...

300 - Social sciences...

Series
European respiratory journal
ISSN or ISBN (if monograph)
0903-1936
Publisher
European Respiratory Society
Language
English
Publisher DOI
10.1183/13993003.01574-2021
PubMed ID
34649974
Description
BACKGROUND

High-flow nasal cannula (HFNC) has become a frequently used non-invasive form of respiratory support in acute settings, however evidence supporting its use has only recently emerged. These guidelines provide evidence-based recommendations for the use of HFNC alongside other noninvasive forms of respiratory support in adults with acute respiratory failure (ARF).

MATERIALS AND METHODOLOGY

The European Respiratory Society Task Force panel included expert clinicians and methodologists in pulmonology and intensive care medicine. The Task Force used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) methods to summarise evidence and develop clinical recommendations for the use of HFNC alongside conventional oxygen therapy (COT) and non-invasive ventilation (NIV) for the management of adults in acute settings with ARF.

RESULTS

The Task Force developed 8 conditional recommendations, suggesting using: 1) HFNC over COT in hypoxemic ARF, 2) HFNC over NIV in hypoxemic ARF, 3)HFNC over COT during breaks from NIV, 4) either HFNC or COT in post-operative patients at low risk of pulmonary complications, 5) either HFNC or NIV in post-operative patients at high risk of pulmonary complications, 6) HFNC over COT in non-surgical patients at low risk of extubation failure, 7) NIV over HFNC for patients at high risk of extubation failure unless there are relative or absolute contraindications to NIV, 8) trialling NIV prior to use of HFNC in patients with chronic obstructive pulmonary disease (COPD) and hypercapnic ARF.

CONCLUSIONS

HFNC is a valuable intervention in adults with ARF. These conditional recommendations can assist clinicians in choosing the most appropriate form of non-invasive respiratory support to provide to patients in different acute settings.
Related URL
https://erj.ersjournals.com/lens/erj/early/2021/09/29/13993003.01574-2021
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/53793
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
Oczkowski_EurRespirJ_2021_AAM.pdftextAdobe PDF6.84 MBpublisheracceptedOpen
Oczkowski_EurRespirJ_2022.pdftextAdobe PDF672.3 KBpublisherpublished restricted
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo